Company Overview and News

9
TD Ameritrade Invests in Regulated Crypto Exchange Platform

2018-10-05 zacks
TD Ameritrade Holding Corporation (AMTD - Free Report) is investing in a regulated derivatives exchange and clearing organization — ErisX, with an aim to make digital currency products more accessible to retail clients. Financial terms of the deal were not disclosed.
ETFC VIRT AMTD CG PBB PSEC YY

22
10 Financial Stocks to Consider Before They’re No Longer Worth It

2018-10-05 investorplace - 1
Rising interest rates generally prove a boon for financial stocks, but if turmoil in Turkey turns into an outright contagion that infects the rest of the world, it’s unlikely any sector would be spared regardless of the backdrop. Never mind the fact that the wrong headline can pull the rug out from underneath the market without any warning.
DFS SQ C RF DTK PYPL KEY GS VIRT AMTD ICE ENVA EBAY

3
Trading firm Virtu Financial eyeing brokerage ITG - Bloomberg

2018-10-04 reuters
(Reuters) - High-speed trading firm Virtu Financial Inc (VIRT.O) is looking to buy independent brokerage Investment Technology Group Inc (ITG.N), Bloomberg reported on Thursday, citing people familiar with the matter.
VIRT ITG KCG

2
Stock brokerage giant TD Ameritrade bets on a new cryptocurrency exchange

2018-10-03 cnbc
The U.S. brokerage firm announced a strategic investment Wednesday in an exchange called ErisX, which offers both bitcoin spot and futures trading. High-speed trading company Virtu Financial will also back the exchange.
7018 CME VIRT

4
Ex-Nasdaq boss: SEC's plan to open up private markets will let loose the wolves on regular investors

2018-09-25 cnbc
Should middle class investors be able to get a piece of high-flying private startups like Uber or AirBnb?
NDAQ VIRT SFIX

3
VIRT / Virtu Financial, Inc. 8-K (Current Report)

2018-09-19 sec.gov - 1
UNITED STATES<
VIRT

4
VIRT / Virtu Financial, Inc. 8-K (Current Report)

2018-09-07 sec.gov - 2
UNITED STATES<
VIRT

4
Virtu Financial Announces Additional $74 Million Repayment and Commences Marketing of Repricing Transaction

2018-09-07 globenewswire - 1
NEW YORK, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NASDAQ: VIRT) (the “Company”), a leading technology-enabled market maker and liquidity provider to the global financial markets, today announced further actions to reduce debt and modify its capital structure.
VIRT KCG

2
2 Downtrodden Financial Stocks to Watch: CBOE and VIRT

2018-08-29 investorplace
Wall Street is seemingly beside itself these days as the broader market makes new highs. But if you’re of the mind that investors are due for an unpleasant and volatile wake-up call, one clever partial hedge or portfolio diversifier is a pair of bullish options spreads on down, but not out financials CBOE Global Markets (NASDAQ:CBOE) and Virtu Financial (NASDAQ:VIRT).
CBOE VIRT

2
Virtu Financial (VIRT): Moving Average Crossover Alert

2018-08-28 zacks
Virtu Financial, Inc. (VIRT - Free Report) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for VIRT broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness.
VIRT

11
Hedge funds seek review of market data fees, 'pickles' and all

2018-08-24 reuters
NEW YORK (Reuters) - The two main hedge fund trade groups have joined a growing chorus of stock market participants asking U.S. regulators to reign in “unreasonable” data fees charged by some exchanges, which they said restrict trading and harm competition.
DTK UBS ICE MS C NDAQ CGBBW VIRT ULSGF

8
WEAT / Teucrium Wheat Fund - Stock Institutional Ownership and Shareholders - Fintel.io

2018-08-21 fintel.io
This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
BTE WEAT VIRT BTE ACHN

70
OSN / Ossen Innovation Co., Ltd. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-08-17 fintel.io - 1
This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
OSN VIRT TSCC MARA MS BLDP

22
10 Financial Stocks to Consider Before They’re No Longer Worth It

2018-08-15 investorplace - 1
Rising interest rates generally prove a boon for financial stocks, but if turmoil in Turkey turns into an outright contagion that infects the rest of the world, it’s unlikely any sector would be spared regardless of the backdrop. Never mind the fact that the wrong headline can pull the rug out from underneath the market without any warning.
DFS SQ C RF DTK PYPL KEY GS VIRT AMTD ICE ENVA EBAY

2
What To Make Of Virtu Financial's Recent Price Collapse

2018-08-12 seekingalpha
Virtu Financial is down heavily from its $38+ levels just a few months ago, dropping even more after an earnings report that showed weaker-than-expected earnings.
VIRT

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to VIRT / Virtu Financial, Inc. on message board site Silicon Investor.

Virtual Reality Virtual Reality Virtual Reality Virtual Piggy, Inc. Virtual Piggy, Inc. Virtual Piggy, Inc.
VTSI - VirTra Systems Inc. VTSI - VirTra Systems Inc. VTSI - VirTra Systems Inc. Virtusa Inc. Virtusa Inc. Virtusa Inc.
Alpha Virtual, Inc. (AVUL) To Acquire EssTec, Inc. Alpha Virtual, Inc. (AVUL) To Acquire EssTec, Inc. Alpha Virtual, Inc. (AVUL) To Acquire EssTec, Inc. ITOY - Imagin.Net and Virtual Games, Inc ITOY - Imagin.Net and Virtual Games, Inc ITOY - Imagin.Net and Virtual Games, Inc
VGAM - Virtual Gaming VGAM - Virtual Gaming VGAM - Virtual Gaming Virtual Technology Corporation (OTCBB:VTCO Virtual Technology Corporation (OTCBB:VTCO Virtual Technology Corporation (OTCBB:VTCO
VIRT (Virtual Reality Inc.) - An OTC company.. Anyone??? VIRT (Virtual Reality Inc.) - An OTC company.. Anyone??? VIRT (Virtual Reality Inc.) - An OTC company.. Anyone??? Virtek Vision - machine vision applications Virtek Vision - machine vision applications Virtek Vision - machine vision applications
CUSIP: 928254101